- Forums
- ASX - By Stock
- ILA
- Ann: Grant funding to directly support Phase 2a trial
Ann: Grant funding to directly support Phase 2a trial, page-35
Featured News
Add ILA (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.040(33.3%) |
Mkt cap ! $24.94M |
Open | High | Low | Value | Volume |
13.5¢ | 16.0¢ | 13.0¢ | $66.90K | 472.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 245030 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 245030 | 0.140 |
1 | 8000 | 0.135 |
2 | 40660 | 0.130 |
1 | 9480 | 0.125 |
2 | 17905 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 25000 | 1 |
0.190 | 56048 | 2 |
0.195 | 300000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ILA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online